Ali Asghar Khakshur, Elham Khodaverdi, Hossein Kamali, Ali Nokhodchi
{"title":"An insight into Cell-Penetrating Peptides: Perspectives on Design, Optimization, and Targeting in Drug Delivery Systems.","authors":"Ali Asghar Khakshur, Elham Khodaverdi, Hossein Kamali, Ali Nokhodchi","doi":"10.1080/10837450.2025.2505000","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The authors carried out a comprehensive review of the application of peptides known as cell-penetrating peptides (CPPs) in various drug delivery systems (DDS), with the prospect of achieving novel solutions and ideas to overcome the challenges of DDS, by making them more able to penetrate cells and biological membranes.</p><p><strong>Methods: </strong>A conceptual search was conducted in relevant literature databases (Scopus, PubMed, Web of Science, and Google Scholar) up to 1 April 2025 using keywords such as drug delivery systems, cell-penetrating peptides, CPPs, complexes, conjugates, nanoparticles, dendrimers, exosomes, liquid crystalline, liposomes, micelles, nanospheres and lipid nanoparticles.</p><p><strong>Results: </strong>The studies demonstrate that the antimicrobial effect of drugs, including curcumin, gentamicin, and antifungal drugs like imidazoacridinone derivatives, can be enhanced when they are conjugated or complexed with CPPs. CPPs possess positive charges, which make them suitable for gene therapy applications by facilitating the delivery of plasmids and siRNAs with negative charges in modern delivery systems. Medicinal formulations containing CPPs in combination with liquid crystals or nanostructured lipid carriers (NLCs) increase drugs penetration to the skin. Additionally, several investigations showed that CPPs could have a positive impact on the pharmacokinetic and pharmacodynamic of chemotherapy agents, reducing their side effects.</p><p><strong>Conclusion: </strong>CPPs have significant potential in enhancing penetration, bioavailability, targeting, and optimization of DDS. By using computer modeling and designing CPPs with more desirable features and conducting more clinical studies, new methods for treating diseases and better formulations can be achieved.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-34"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2025.2505000","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The authors carried out a comprehensive review of the application of peptides known as cell-penetrating peptides (CPPs) in various drug delivery systems (DDS), with the prospect of achieving novel solutions and ideas to overcome the challenges of DDS, by making them more able to penetrate cells and biological membranes.
Methods: A conceptual search was conducted in relevant literature databases (Scopus, PubMed, Web of Science, and Google Scholar) up to 1 April 2025 using keywords such as drug delivery systems, cell-penetrating peptides, CPPs, complexes, conjugates, nanoparticles, dendrimers, exosomes, liquid crystalline, liposomes, micelles, nanospheres and lipid nanoparticles.
Results: The studies demonstrate that the antimicrobial effect of drugs, including curcumin, gentamicin, and antifungal drugs like imidazoacridinone derivatives, can be enhanced when they are conjugated or complexed with CPPs. CPPs possess positive charges, which make them suitable for gene therapy applications by facilitating the delivery of plasmids and siRNAs with negative charges in modern delivery systems. Medicinal formulations containing CPPs in combination with liquid crystals or nanostructured lipid carriers (NLCs) increase drugs penetration to the skin. Additionally, several investigations showed that CPPs could have a positive impact on the pharmacokinetic and pharmacodynamic of chemotherapy agents, reducing their side effects.
Conclusion: CPPs have significant potential in enhancing penetration, bioavailability, targeting, and optimization of DDS. By using computer modeling and designing CPPs with more desirable features and conducting more clinical studies, new methods for treating diseases and better formulations can be achieved.
目的:对细胞穿透肽(CPPs)在各种药物传递系统(DDS)中的应用进行了全面的综述,并展望了通过使其更能穿透细胞和生物膜来克服DDS挑战的新解决方案和思路。方法:在截至2025年4月1日的相关文献数据库(Scopus、PubMed、Web of Science和谷歌Scholar)中进行概念检索,检索关键词为药物传递系统、细胞穿透肽、CPPs、配合物、缀合物、纳米颗粒、树状大分子、外体、液晶、脂质体、胶束、纳米球和脂质纳米颗粒。结果:研究表明姜黄素、庆大霉素以及咪唑吖啶酮衍生物等抗真菌药物与CPPs偶联或络合可增强其抗菌作用。CPPs具有正电荷,这使得它们适合于基因治疗的应用,在现代的递送系统中,它们可以促进携带负电荷的质粒和sirna的递送。含有CPPs与液晶或纳米结构脂质载体(nlc)结合的药物配方增加了药物对皮肤的渗透。此外,一些研究表明,CPPs可能对化疗药物的药代动力学和药效学产生积极影响,减少其副作用。结论:CPPs在提高DDS的穿透性、生物利用度、靶向性和优化方面具有显著的潜力。通过计算机建模,设计具有更理想特征的cps,并开展更多的临床研究,可以获得新的治疗疾病的方法和更好的配方。
期刊介绍:
Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.
Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:
-Preformulation and pharmaceutical formulation studies
-Pharmaceutical materials selection and characterization
-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
-QbD in the form a risk assessment and DoE driven approaches
-Design of dosage forms and drug delivery systems
-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
-Drug delivery systems research and quality improvement
-Pharmaceutical regulatory affairs
This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.